1. Exogenous Urokinase Inhibits Proteasomal Degradation of Its Cognate Urokinase Plasminogen Activator Receptor
   Ran Zhu et al, 2022, Frontiers in Pharmacology CrossRef
2. Prevalence and Risk Factors of Pulmonary Embolism in COPD Patients Complicated with Secondary Polycythemia
   Jimei Li et al, 2024, International Journal of Chronic Obstructive Pulmonary Disease CrossRef
3. MicroRNA 449a can Attenuate Protective Effect of Urokinase Against Pulmonary Embolism
   Ran Zhu et al, 2022, Frontiers in Pharmacology CrossRef
4. Recombinant hirudin attenuates pulmonary hypertension and thrombosis in acute pulmonary embolism rat model
   Xiang Wei et al, 2024, PeerJ CrossRef
5. Could SARS-CoV-2 blocking of ACE2 in endothelial cells result in upregulation of CX3CL1, promoting thrombosis in COVID-19 patients?
   Selma Rivas-Fuentes et al, 2021, Medical Hypotheses CrossRef
6. Increased inflammatory mediators levels are associated with clinical outcomes and prolonged illness in severe COVID-19 patients
   Wendong Hao et al, 2023, International Immunopharmacology CrossRef